In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrel.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 33075264.
- Also identified by DOI 10.7326/ACPJ202010200-044.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Navarese EP, Khan SU, Kolodziejczak M, et al. <b>Comparative efficacy and safety of oral P2Y</b> <sub><b>12</b></sub> <b>inhibitors in acute coronary syndrome: network meta-analysis of 52 816 patients from 12 randomized trials.</b> Circulation. 2020;142:150-60. 32468837.
Medical subject headings
- Acute Coronary Syndrome